Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
DDAH1 belongs to the dimethylarginine dimethylaminohydrolase (DDAH) gene family. Additionally we are shipping DDAH1 Proteins (16) and DDAH1 Kits (13) and many more products for this protein.
Showing 10 out of 72 products:
Chicken Polyclonal DDAH1 Primary Antibody for IHC, WB - ABIN2785922
Deer, Krames, Hassenbusch, Burton, Caraway, Dupen, Eisenach, Erdek, Grigsby, Kim, Levy, McDowell, Mekhail, Panchal, Prager, Rauck, Saulino, Sitzman, Staats, Stanton-Hicks, Stearns, Dean Willis, Witt, Follett, Huntoon, Liem, Rathmell, Wallace, Buchser, Cou: Management of Intrathecal Catheter-Tip Inflammatory Masses: An Updated 2007 Consensus Statement From An Expert Panel. in Neuromodulation : journal of the International Neuromodulation Society 2011
Show all 2 references for ABIN2785922
Chicken Polyclonal DDAH1 Primary Antibody for IHC, WB - ABIN2785923
Kim, Park, Park, Jung, Pang, Ryu, Lee, Eom, Park: No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations. in Twin research and human genetics : the official journal of the International Society for Twin Studies 2008
Show all 2 references for ABIN2785923
Human Polyclonal DDAH1 Primary Antibody for ELISA, WB - ABIN268699
Pullamsetti, Kiss, Ghofrani, Voswinckel, Haredza, Klepetko, Aigner, Fink, Muyal, Weissmann, Grimminger, Seeger, Schermuly: Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005
Show all 2 references for ABIN268699
Human Polyclonal DDAH1 Primary Antibody for ICC, IF - ABIN4305227
Shao, Wang, Shrestha, Thakur, Borowski, Sweet, Thomas, Moravec, Hazen, Tang: Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1. in Journal of the American College of Cardiology 2012
Cow (Bovine) Polyclonal DDAH1 Primary Antibody for WB - ABIN374149
Kimoto, Miyatake, Sasagawa, Yamashita, Okita, Oka, Ogawa, Tsuji: Purification, cDNA cloning and expression of human NG,NG-dimethylarginine dimethylaminohydrolase. in European journal of biochemistry / FEBS 1999
Human Polyclonal DDAH1 Primary Antibody for EIA, WB - ABIN452906
Ellger, Richir, van Leeuwen, Debaveye, Langouche, Vanhorebeek, Teerlink, Van den Berghe: Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity. in Endocrinology 2008
results suggest that miR (show MLXIP Antibodies)-21 may regulate renal fibrosis by the Wnt (show WNT2 Antibodies) pathway via directly targeting DDAH1
The most significant associations were detected for PECAM1 (show PECAM1 Antibodies)*V/V + DDAH1*C (OR = 4.17 CI 1.56-11.15 Pperm = 0.005)
FoxO1 (show FOXO1 Antibodies) regulates asymmetric dimethylarginine via downregulation of dimethylaminohydrolase 1 in HUVECs and subjects with carotid atherosclerosis.
Inhibiting the expression of DDAH1, but not DDAH2 (show DDAH2 Antibodies), resulted in a significant increase in the sensitivity of the EVT cell line SGHPL-4 to tumour necrosis factor (show TNF Antibodies) related apoptosis inducing ligand (TRAIL) induced apoptosis
Genebased analyses revealed associations of the DDAH1 gene with longitudinal Blood Pressure phenotypes, associations with essential hypertension, Blood Pressure salt sensitivity, preeclampsia, or preclinical stages of atherosclerosis.
increased ADMA levels in rheumatoid arthritis do not appear to relate to DDAH (show DDAH2 Antibodies) genetic polymorphisms
DDAH1 deficiency attenuates endothelial cell cycle progression and angiogenesis.
the advanced glycation end products-receptor (show AGER Antibodies) for advanced glycation end products-mediated reactive oxygen species generation could be involved in endothelial dysfunction in diabetic end-stage renal disease patients
DDAH1 genotypes were closely related to asymmetric dimethylarginine levels, but not to measures of endothelium-dependent vasodilation in an elderly population.
Only the DDAH1-V1 transcript is responsible for ADMA metabolism, and transcript specific primers are recommended to determine DDAH1 mRNA expression.
dimethylargininase-1 inhibited upon specific Cys (show DNAJC5 Antibodies)-S-nitrosylation.
High-resolution crystal structures of DDAH (show DDAH2 Antibodies) isoform 1 was presented.
Demonstrate a critical role for DDAH-1 and endogenous methylarginines in the pathogenesis of endothelial dysfunction.
DDAH-1 and DDAH-2 (show DDAH2 Antibodies) manifest their effects through different mechanisms, the former of which is largely ADMA-dependent and the latter ADMA-independent.
A time-dependent decrease in serum and tissue ADMA and increase in mRNA expression of DDAH-1 and PRMT-1 as well as higher rates of mRNA expression of CAT-1 and lower rates of CAT-2A and CAT-2B were found after 8-week MCD diet.
our results suggest that DDAH1 not only acts as an enzyme degrading ADMA but also controls cellular oxidative stress and apoptosis via a miR (show MLXIP Antibodies)-21-dependent pathway.
In mild CKD, dysregulation of the ADMA/DDAH (show DDAH2 Antibodies) pathway in adipose tissue triggers lipodystrophy-like phenotype changes, including ectopic fat depositions.
Endothelial deletion of DDAH1 profoundly impairs the angiogenic capacity of endothelial cells.
Our findings suggest that decreased expression of DDAH1 and DDAH2 (show DDAH2 Antibodies) in the lungs may contribute to allergic asthma and overexpression of DDAH1 attenuates allergen-induced airway inflammation through modulation of Th2 responses.
Overexpression of the ADMA degrading enzyme, DDAH1, did not ameliorate atherosclerosis in ApoE (show APOE Antibodies)-deficient subtotally nephrectomized mice.
DDAH1 overexpression selectively decreased the sustained phase of hypoxic pulmonary vasoconstriction, partly via activation of the NO-cGMP pathway.
Pharmacological and genetic reduction of DDAH1 activity is protective against the vascular changes observed during endotoxic shock.
Data show that DDAH (show DDAH2 Antibodies) inhibition reduces fibroblast-induced collagen deposition in an ADMA-independent manner and reduces abnormal epithelial proliferation in an ADMA-dependent manner.
This gene belongs to the dimethylarginine dimethylaminohydrolase (DDAH) gene family. The encoded enzyme plays a role in nitric oxide generation by regulating cellular concentrations of methylarginines, which in turn inhibit nitric oxide synthase activity.
dimethylarginine dimethylaminohydrolase 1
, N(G),N(G)-dimethylarginine dimethylaminohydrolase 1
, NG, NG-dimethylarginine dimethylaminohydrolase
, NG,NG dimethylarginine dimethylaminohydrolase